HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx-to-OTC Switch Of Menopause Treatment Approved In UK

Executive Summary

Women in the UK will soon have OTC access to a low-dose Hormone Replacement Therapy drug following the reclassification of Novo Nordisk's Gina.

You may also be interested in...



P&G Clearblue Line Extension, Kenvue Survey Of 4,500 Women Target Menopause Market

P&G announces Clearblue Menopause Stage Indicator launch noting more than two in three women feel unprepared for menopause and less than half say they have enough information to manage it. Kenvue survey results show prior to age 50, proportion of women experiencing symptoms attributable to menopause is significantly greater than the proportion that self-reports.

PAGB Survey Shows Brits Losing Confidence In Self-Care, Time For UK Government To Act

UK consumers “may be falling back into pre-pandemic behaviours and there is a time-limited opportunity to embed the changes people had embraced during the pandemic,” argues PAGB CEO Michelle Riddalls as the association publishes its latest self-care survey. 

Novo Nordisk Launches OTC HRT Treatment In UK

The first hormone replacement therapy drug sold without a prescription in the UK is now available in Boots pharmacies across the country.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel